- Home
- REE vs INZY Comparison
REE vs INZY Comparison
Compare REE & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- INZY
- Stock Information
- Founded
- REE 2011
- INZY 2015
- Country
- REE Israel
- INZY United States
- Employees
- REE N/A
- INZY N/A
- Industry
- REE Auto Manufacturing
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- INZY Health Care
- Exchange
- REE Nasdaq
- INZY Nasdaq
- Market Cap
- REE 70.5M
- INZY 64.9M
- IPO Year
- REE N/A
- INZY 2020
- Fundamental
- Price
- REE $2.97
- INZY $1.19
- Analyst Decision
- REE Strong Buy
- INZY Strong Buy
- Analyst Count
- REE 3
- INZY 9
- Target Price
- REE $12.50
- INZY $17.22
- AVG Volume (30 Days)
- REE 99.3K
- INZY 1.1M
- Earning Date
- REE 05-29-2025
- INZY 05-20-2025
- Dividend Yield
- REE N/A
- INZY N/A
- EPS Growth
- REE N/A
- INZY N/A
- EPS
- REE N/A
- INZY N/A
- Revenue
- REE $626,000.00
- INZY N/A
- Revenue This Year
- REE N/A
- INZY N/A
- Revenue Next Year
- REE $18,744.14
- INZY N/A
- P/E Ratio
- REE N/A
- INZY N/A
- Revenue Growth
- REE N/A
- INZY N/A
- 52 Week Low
- REE $2.31
- INZY $0.72
- 52 Week High
- REE $11.72
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- REE 45.84
- INZY 56.87
- Support Level
- REE $2.68
- INZY $1.18
- Resistance Level
- REE $3.25
- INZY $1.63
- Average True Range (ATR)
- REE 0.24
- INZY 0.19
- MACD
- REE 0.11
- INZY 0.03
- Stochastic Oscillator
- REE 52.31
- INZY 38.93
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.